£12.5M
The seed round was led by BGF with participation from F-Prime Capital, Kindred Capital, and Jonathan Milner.
Shift Bioscience
Shift Bioscience uses generative artificial intelligence models to understand how gene activation can reverse the aging process.
£12.5MTotal raised
Shift Bioscience is a biotechnology company based in Cambridge that uses generative artificial intelligence models to understand how gene activation can reverse the aging process.
Categories
Founders
DI
Daniel Ives
CEO
BS
Brendan Swain
CSO